<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Voukia F</submitter><funding>European Research Council</funding><funding>Lundbeck Foundation</funding><pagination>477</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12899889</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(3)</volume><pubmed_abstract>Histone lysine acetylation is a widespread posttranslational modification, essential for vital functions in eukaryotic organisms. Histone lysine acetyltransferases (KATs) employ acetyl-coenzyme A as a universal acetyl donor for acetylation of lysine residues in histone and non-histone proteins. Despite the biomedicinal importance of modulation of the KAT activity, application of the acetyl-coenzyme A cosubstrate structure for the design of potent and selective inhibitors has been underexplored. Here, we developed functionalized coenzyme A analogs as inhibitors against human histone lysine acetyltransferases GCN5, KAT8, and HAT1. In contrast to the unmodified coenzyme A, which was found to be a poor inhibitor of GCN5 and KAT8 (IC&lt;sub>50&lt;/sub> > 150 μM), we showed that a ketone-substituted c</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Inhibition of Histone Lysine Acetyltransferases by Coenzyme A Analogs.</pubmed_title><pmcid>PMC12899889</pmcid><funding_grant_id>715691</funding_grant_id><funding_grant_id>R344-2020-1051</funding_grant_id><pubmed_authors>Andersen SB</pubmed_authors><pubmed_authors>Bilgin N</pubmed_authors><pubmed_authors>Mecinovic J</pubmed_authors><pubmed_authors>Voukia F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of Histone Lysine Acetyltransferases by Coenzyme A Analogs.</name><description>Histone lysine acetylation is a widespread posttranslational modification, essential for vital functions in eukaryotic organisms. Histone lysine acetyltransferases (KATs) employ acetyl-coenzyme A as a universal acetyl donor for acetylation of lysine residues in histone and non-histone proteins. Despite the biomedicinal importance of modulation of the KAT activity, application of the acetyl-coenzyme A cosubstrate structure for the design of potent and selective inhibitors has been underexplored. Here, we developed functionalized coenzyme A analogs as inhibitors against human histone lysine acetyltransferases GCN5, KAT8, and HAT1. In contrast to the unmodified coenzyme A, which was found to be a poor inhibitor of GCN5 and KAT8 (IC&lt;sub>50&lt;/sub> > 150 μM), we showed that a ketone-substituted c</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-09T13:12:22.99Z</modification><creation>2026-07-09T13:09:13.589Z</creation></dates><accession>S-EPMC12899889</accession><cross_references><pubmed>41683453</pubmed><doi>10.3390/molecules31030477</doi></cross_references></HashMap>